Effective prophylaxis for deep venous thrombosis after stroke: Both low-dose anticoagulation and stockings for most cases

Stroke

Volumn 35, Issue 12, 2004, Pages 2910-

  Davis, Stephen M ^a,c   Donnan, Geoffrey A ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Deep vein thrombosis; Heparin; Pulmonary embolism; Stroke

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR; XIMELAGATRAN;

ARTICLE; BLEEDING; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG TOLERABILITY; HUMAN; LOW DRUG DOSE; LUNG EMBOLISM; PRIORITY JOURNAL; PROPHYLAXIS; STROKE;

ANTICOAGULANTS; BANDAGES; CEREBROVASCULAR ACCIDENT; HUMANS; RISK; VENOUS THROMBOSIS;

EID: 9444222496     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000147722.86433.26     Document Type: Article

References (6)

1. Cadilhac DA, Ibrahim J, Pearce DC, Ogden KH, McNeill J, Davis SM, Donnan GA. A multi-center comparison of processes of care between Stroke Units and conventional care wards in Australia. Stroke. 2004;35: 1035-1040.
2. Counsell C, Sandercock P. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke (Cochrane Review). In: The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd; 2004:2.
3. Amaragiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis (Cochrane Review). In: The Cochrane Library, Chichester, UK: John Wiley & Sons, Ltd; 2004:2.
4. Hillbom M, Erila T, Sotaniemi K, Tatlisumak T, Sarna S, Kaste M. Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomised, double-blind study. Acta Neurol Scand. 2002;106:84-92.
5. National Library of Medicine. ClinicalTrial.gov. Available at: http://www.clinicaltrials.gov. Accessed October 13, 2004.
6. Donnan GA, Dewey HM, Chambers BR. Warfarin for atrial fibrillation: the end of an era? Lancet Neurol. 2004;3:305-308.